Abstract
Salivary gland tumors account for approximately 5% of all head and neck tumors, with a global annual incidence of 0.4 to 13.5 cases/100.000 persons. Because of its wide microscopic diversity the diagnosis of these neoplasms becomes a frequent pitfall in the histopathology routine and the classification of this group of lesions is frequently being updated. In the last years new entities ha…